Clinical trial Recruiting at 1 site Observational

Registry for patients with structural ventricular arrhythmias in China

Official title: China Structural Ventricular Arrhythmias Registry, a Multicenter,Observational and Prospective Study.

Run by China National Center for Cardiovascular Diseases · NCT03821051 · Data updated 2026-11-12

This study is trying to find out how common serious heart rhythm problems are in China and what factors might increase the risk for people with these conditions by collecting health information from 2000 participants.

Quick facts

Study typeObservational
SexAll
Enrollment2000 (estimated)
SponsorChina National Center for Cardiovascular Diseases
Government
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedOctober 24, 2017
Main results expectedOctober 24, 2022
Study endsOctober 24, 2027
Registry record updatedJanuary 29, 2019
Trial IDNCT03821051 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals diagnosed with ventricular arrhythmias resulting from structural heart diseases such as ischemic cardiomyopathy or dilated cardiomyopathy.

Probably not a fit

Patients without a definitive diagnosis of ventricular arrhythmia or those with arrhythmias not related to structural heart diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational, prospective, multi-center registry aims to build a risk stratification for malignant structural ventricular arrhythmias by recruiting 2000 participants from 10 major arrhythmia centers across China. Participants will have their clinical data abstracted from medical records and blood samples collected to identify promising risk indicators. Follow-ups will occur every six months to monitor the condition of arrhythmia and related clinical events. The study seeks to clarify the prevalence and risk factors associated with these arrhythmias in the Chinese population.

Why it matters

Potential benefit: If successful, this study could lead to improved risk assessment and early prevention strategies for patients with malignant ventricular arrhythmias.

How similar studies have gone: Other studies focusing on risk stratification for ventricular arrhythmias have shown promise, but this specific registry approach is novel in the Chinese context.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* diagnosed as ventricular arrhythmia resulted by structural heart diseases, including ischemic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, dilated cardiomyopathy, hypertrophic cardiomyopathy, etc.

Exclusion Criteria:

* none

Where it's running

  • China National Center for Cardiovascular Diseases
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.